A randomized comparison of Chloroquine versus Dihydroartemisinin-Piperaquine for the treatment of Plasmodium vivax infection in Vietnam
A total of 128 Vietnamese patients with symptomatic Plasmodium vivax mono-infections were enrolled in a prospective, open-label, randomized trial to receive either chloroquine or dihydroartemisinin–piperaquine (DHA-PPQ). The proportions of patients with adequate clinical and parasitological response...
Huvudupphovsmän: | Thuan, P, Ca, N, Toi, P, Nhien, N, Thanh, N, Anh, N, Phu, N, Thai, C, Thai, L, Hoa, N, Dong, L, Loi, M, Son, D, Khanh, T, Dolecek, C, Nhan, H, Wolbers, M, Thwaites, G, Farrar, J, White, N, Hien, T |
---|---|
Materialtyp: | Journal article |
Publicerad: |
American Society of Tropical Medicine and Hygiene
2016
|
Liknande verk
Liknande verk
-
A randomized comparison of chloroquine versus dihydroartemisinin-piperaquine for the treatment of Plasmodium vivax infection in Vietnam
av: Thuan, PD, et al.
Publicerad: (2016) -
Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam
av: Thanh, N, et al.
Publicerad: (2017) -
Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
av: Awab, G, et al.
Publicerad: (2010) -
Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
av: Phyo, A, et al.
Publicerad: (2011) -
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
av: Ashenafi Assefa, et al.
Publicerad: (2022-12-01)